Ing Sarah 4
4 · Marex Group plc · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Marex Group (MRX) Director Ing Sarah Receives Restricted Award
What Happened
Director Ing Sarah received a restricted share award from Marex Group plc representing 2,070 ordinary shares. The award was reported as an acquisition at $0.00 per share (total reported value $0) on 2026-06-09 and filed on 2026-06-11.
Key Details
- Transaction date: 2026-06-09; Filing date: 2026-06-11 (filed within the typical two-business-day Form 4 window).
- Instrument: Restricted share awards (reported as an award/grant, code A).
- Shares awarded: 2,070 ordinary shares; price per share reported: $0.00; total reported consideration: $0.
- Shares owned after transaction: Not specified in this filing.
- Footnote (F1): The 2,070 shares are underlying restricted share awards—each award is a contingent right to receive one ordinary share upon vesting and settlement.
Context
Restricted share awards are typically compensation or retention awards and do not represent an open-market purchase or sale. Because these shares are contingent on future vesting/settlement (per the footnote), they do not immediately increase the insider’s freely tradable holdings. This filing is informational and does not, by itself, indicate a buy or sell sentiment.
Insider Transaction Report
Form 4
Ing Sarah
Director
Transactions
- Award
Ordinary Shares
[F1]2026-06-09+2,070→ 10,895 total
Holdings
- 535(indirect: By Spouse)
Ordinary Shares
Footnotes (1)
- [F1]The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Signature
/s/ Scott Linsley as Attorney-in-Fact, for Sarah Ing|2026-06-11